Phase 1 Evaluation of [64Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors

A. Craig Lockhart, Yongjian Liu, Farrokh Dehdashti, Richard Laforest, Joel Picus, Jennifer Frye, Lauren Trull, Stefanie Belanger, Madhuri Desai, Syed Mahmood, Jeanne Mendell, Michael J. Welch, Barry A. Siegel

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1 Evaluation of [<sup>64</sup>Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences